These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6314546)

  • 21. [Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].
    Strasser R; Klepzig H; Ostrowski J; Resag K
    MMW Munch Med Wochenschr; 1983 Feb; 125(8):156-8. PubMed ID: 6405248
    [No Abstract]   [Full Text] [Related]  

  • 22. Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
    Balestrini AE; Menzio AC; Cabral R; Feldman R; Mercogliano C; Flichtentrei D; Albera HP; Vazquez A
    Eur J Clin Pharmacol; 1984; 27(1):1-5. PubMed ID: 6386486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molsidomine, an effective long-acting anti-anginal drug.
    Balakumaran K; Hugenholtz PG; Tijssen JG; Chadha DR
    Eur Heart J; 1983 Sep; 4(9):655-61. PubMed ID: 6416844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and hemodynamic effect of molsidomine in patients with unstable angina pectoris].
    Beloev I; Tomov I; Elenkova A; Terzieva L
    Vutr Boles; 1982; 21(3):62-9. PubMed ID: 6810552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and hemodynamic effects of the new dilator drug molsidomine.
    Malcolm AD
    Am Heart J; 1985 Mar; 109(3 Pt 2):674-7. PubMed ID: 3883734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of angina pectoris with molsidomin: results of a double-blind study for assessment of rate of anginal attacks, exercise reaction, and systolic time intervals (author's transl)].
    Mannes GA; Goebel G; Kafka W; Rudolph W
    Herz; 1978 Jun; 3(3):172-84. PubMed ID: 363584
    [No Abstract]   [Full Text] [Related]  

  • 28. The antianginal effect of molsidomine in prolonged oral therapy. A double blind, crossover, randomized study.
    Baudry C
    Acta Cardiol; 1982; 37(1):23-30. PubMed ID: 7044013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of molsidomine in the long-term treatment of exertional angina pectoris and chronic congestive heart failure.
    Rudolph W; Dirschinger J
    Am Heart J; 1985 Mar; 109(3 Pt 2):670-4. PubMed ID: 3883733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molsidomine--an effective antianginal drug. Results of an acute randomized stress-testing study.
    Mindlin de Aptecar FR; Vazquez A; Aptecar M
    Cardiology; 1985; 72(4):185-92. PubMed ID: 3902224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic effects of molsidomine.
    Rakovec P
    J Cardiovasc Pharmacol; 1980; 2(6):893-4. PubMed ID: 6160337
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Molsidomine prevention of coronary artery spasm caused by alkalosis].
    Weber S; Kahan A; Pailleret JJ; Guérin F; Degeorges M
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):545-9. PubMed ID: 6689397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute double blind trial of a new anti-anginal drug: molsidomine.
    Guerchicoff S; Vazquez A; Kunik H; Drajer S; Díaz F
    Eur J Clin Pharmacol; 1978 Jun; 13(4):247-50. PubMed ID: 352706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of metoprolol with molsidomine in the treatment of angina pectoris.
    van Mantgem JP; Lie KI; Matroos AW
    Eur J Clin Pharmacol; 1985; 28(2):109-11. PubMed ID: 3838725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Other drugs used in angina pectoris].
    Combes P; Richard M; Fargnoli JM
    Soins Cardiol; 1985 Dec; (34):27-32. PubMed ID: 3854549
    [No Abstract]   [Full Text] [Related]  

  • 38. [We need molsidomine for complete prevention of ischemia. Interview with Prof. Rudolph on the therapy of coronary heart disease].
    Rudolph W
    Fortschr Med; 1986 Apr; 104(13):52. PubMed ID: 3754533
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience with molsidomin].
    Schlimmer P
    ZFA (Stuttgart); 1980 Mar; 56(9):610-1. PubMed ID: 7376699
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of molsidomine in patients with coronary disease].
    Goch JH; Rosiek S; Brzozowski R; Bała T; Tkaczewski W; Adamska-Dyniewska H
    Pol Tyg Lek; 1985 Jul; 40(29):829-31. PubMed ID: 3903695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.